Medical Cyclotron Market Trends

  • Report ID: 1112
  • Published Date: Dec 23, 2024
  • Report Format: PDF, PPT

Medical Cyclotron Market Trends

Growth Drivers

Rising Cases of Cancer and Increasing Demand for Nuclear Scans to Boost the Market Growth

Lifestyle changes such as smoking and excess consumption of tobacco are the factors resulting in rise in cancer prevalence among majority of the population. According to the International Agency for Research on Cancer (IARC), in 2018, there were about 17 million new cancer cases and 9.5 million deaths due to cancer. Since there is a demand for accurate diagnosis of cancer at an early stage owing to increase in cancer awareness among the people, the demand for medical cyclotron is high. This is anticipated to significantly expand the medical cyclotron market. 

Advancement in Medical Imaging Technologies to Drive the Market Growth

The advancement in healthcare technology all over the world is improving at a fast pace owing to the increasing number of cases of various medical problems. As per the World Nuclear Association, the global radioisotope market was valued at $9.6 billion in 2016 and it is expected to reach about $17 billion by 2021. This results in the inclination towards advanced diagnostic methods like nuclear scans and growing acceptance of PET medical accelerators for the treatment of cancer. On the back of these, the market is predicted to grow over the forecast period. 

Challenges

High Costs and Regulatory Constraints to Hamper the Market Growth

Factors such as high maintenance and operating costs associated with the cyclotron equipment coupled with the strict government regulations to be used in commercial purpose negatively affect the market growth. Also, lack of expertise to operate cyclotrons is estimated to hinder the growth of medical cyclotron market in the future.

Medical Cyclotron Market: Key Insights

Increasing number of cancer patients and wide-scale applications of medical cyclotrons in production of medical isotopes coupled with its increased efficiency in the treatment of cancer are some of the significant factors boosting the market growth. The medical cyclotron market is anticipated to record a significant CAGR over the forecast period, i.e., 2020-2028. The market is segmented by energy into 10-12 MeV, 16-18 MeV, 19-24 MeV and 24 MeV. Among these segments, the segment for 16-18 MeV is anticipated to hold the leading share in the market on account of its small size compared to other particle accelerators along with the rise in demand for nuclear scans in hospitals owing to increasing incidence rate of cancer. Further, these cyclotrons are also required in universities and local industrial radionuclide plants. The 19-24 MeV based energy segment, on the other hand, is anticipated to grow at the highest rate in the medical cyclotron market as a result of its wide scale application in production of SPECT and PET radioisotopes used for medical researches. Additionally, they are the most cost-effective and best suited for diagnostic of patients and radio-pharmaceutical commercial plants.

Base Year

2024

Forecast Year

2025-2037

CAGR

10.8%

Base Year Market Size (2024)

USD 254.14 million

Forecast Year Market Size (2037)

USD 964.03 million

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 1112
  • Published Date: Dec 23, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of medical cyclotron is evaluated at USD 277.47 million.

Medical Cyclotron Market size was over USD 254.14 million in 2024 and is poised to exceed USD 964.03 million by 2037, witnessing over 10.8% CAGR during the forecast period i.e., between 2025-2037.

North America industry is estimated to hold largest revenue share by 2037, led by soaring demand for nuclear scans owing to rise in cases of cancer and increasing capital investments in healthcare infrastructure.

The major players in the market are GE Healthcare, Siemens Healthineers, IBA Worldwide, Sumitomo Heavy Industries, Ltd., Advanced Cyclotron Systems, Inc., Nueclear Healthcare Limited, TeamBest, Best Cyclotron Systems, Inc. (BCSI), and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample